MFs buy renewables, cement and pharma in October

With the equity market outlook turning uncertain in the wake of the 6.2% drop in the Nifty in October, domestic fund managers adopted a stock-specific approach. They considered themes that have a long runway for growth.

Rising electricity demand and ambitious targets for renewable energy capacity expansion, over the next few years led to fund managers buying stocks like NHPC, KEI, Inox Wind Energy and IEX.

With government spending likely to resume in the second-half of the fi nancial year, some fund managers bought into cement stocks like Ramco Cement and Ambuja Cement.


Some valueconscious fund managers, who believe that the markets are likely to correct further, moved a part of their portfolio to defensive pharma stocks like Zydus Lifesciences, Laurus Labs, Torrent Pharma and Aarti Drugs.